Alterity Therapeutics (ATHE) Invested Capital (2015 - 2025)
Alterity Therapeutics' quarterly Invested Capital came in at -$146.4 million in Q2 2025, down 1609.86% year-on-year from $9.7 million in Q2 2024, and down 1609.86% quarter-over-quarter from $9.7 million in Q2 2024.
Alterity Therapeutics has reported Invested Capital for 11 years, with the latest figure at -$146.4 million in Q2 2025.
- For the quarter ending Q2 2025, Invested Capital fell 1609.86% year-over-year to -$146.4 million; the trailing twelve-month figure through Jun 2025 stood at -$146.4 million (down 1609.86% YoY), and the FY2025 full-year result was -$146.4 million, down 1.43% from the prior year.
- Invested Capital for Q2 2025 stood at -$146.4 million, down from $9.7 million in the prior quarter.
- The five-year high for Invested Capital was $21.7 million in Q2 2022, with the low at -$146.4 million in Q2 2025.
- Average Invested Capital over 5 years is -$16.2 million, with a median of $12.8 million recorded in 2023.
- Year-over-year, Invested Capital jumped 549.48% in 2021 and sank 1609.86% in 2025.
- Tracing ATHE's Invested Capital over 5 years: stood at $21.5 million in 2021, then increased by 0.82% to $21.7 million in 2022, then slumped by 41.12% to $12.8 million in 2023, then retreated by 23.98% to $9.7 million in 2024, then slumped by 1609.86% to -$146.4 million in 2025.
- The last three Invested Capital figures came in at -$146.4 million (Q2 2025), $9.7 million (Q2 2024), and $12.8 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -146.42 Mn |
| Jun 30, 2024 | -144.35 Mn |
| Jun 30, 2023 | 12.76 Mn |
| Jun 30, 2022 | 21.66 Mn |
| Jun 30, 2021 | 21.49 Mn |
| Jun 30, 2020 | 3.31 Mn |
| Jun 30, 2019 | 9.69 Mn |
| Jun 30, 2018 | 13.73 Mn |
| Jun 30, 2017 | 17.80 Mn |
| Jun 30, 2016 | 23.42 Mn |
| Dec 31, 2015 | 424.62 |
| Jun 30, 2015 | 9.33 |